Literature DB >> 16890173

Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis.

Toshio Fukusato1, Junichi Fukushima, Junji Shiga, Yoshihisa Takahashi, Toshiyuki Nakano, Shiro Maeyama, Uchikoshi Masayuki, Makoto Ohbu, Toshiharu Matsumoto, Koji Matsumoto, Hiroshi Hano, Michiie Sakamoto, Fukuo Kondo, Akio Komatsu, Takashi Ishikawa, Hiroo Ohtake, Hajima Takikawa, Kenichi Yoshimura.   

Abstract

Pathological assessment is considered as the gold standard for the diagnosis of nonalcoholic steatohepatitis (NASH). However, there is no agreement of histological features required for the diagnosis of NASH. In the present study, eight experienced hepatopathologists read liver biopsy specimen slides of 21 cases of NASH and suspected NASH independently and were asked to assess histopathological features and render a diagnosis. Interobserver variation among pathologists was evaluated by kappa statistics. Significant, good agreement was present in evaluation of the extent of steatosis and grade of fibrosis. Agreement was moderate concerning the localization of steatosis, localization of fibrosis, and glycogen nuclei. Only slight or poor agreement was seen in evaluation of type of steatosis, ballooning, intralobular necroinflammatory change, portal inflammation, and degree of neutrophilic infiltration. Thus the agreement varied for histological variables. Significant, moderate agreement was seen in the diagnosis of NASH but agreement was poor in the diagnosis of suggestive NASH. The agreement for the diagnosis of NASH was not high as for the individual histological findings that were thought to be the basis of the diagnosis. In conclusion, some histological features in NASH might prove useful for the development of a standardized and reliable pathological diagnosis and scoring system.

Entities:  

Year:  2005        PMID: 16890173     DOI: 10.1016/j.hepres.2005.09.018

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  20 in total

Review 1.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Automated quantification of fibrosis-related parameters using dual-photon microscopy replace diagnosis of pathologists in NAFLD.

Authors:  Yoshio Sumida; Takeshi Okanoue; Atsushi Nakajima
Journal:  Hepatobiliary Surg Nutr       Date:  2020-12       Impact factor: 7.293

3.  The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease.

Authors:  Phunchai Charatcharoenwitthaya; Keith D Lindor; Paul Angulo
Journal:  Dig Dis Sci       Date:  2012-02-29       Impact factor: 3.199

Review 4.  Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshihisa Takahashi; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

5.  Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.

Authors:  Saumya Jayakumar; Stephen A Harrison; Rohit Loomba
Journal:  Curr Hepatol Rep       Date:  2016-04-21

Review 6.  The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.

Authors:  Mangesh R Pagadala; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2012-06-27       Impact factor: 6.126

Review 7.  Can NASH be diagnosed, graded, and staged noninvasively?

Authors:  Garfield A Grandison; Paul Angulo
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

Review 8.  Histological Assessment of NAFLD.

Authors:  Pierre Bedossa
Journal:  Dig Dis Sci       Date:  2016-02-13       Impact factor: 3.199

Review 9.  Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 10.  Role of liver biopsy in nonalcoholic fatty liver disease.

Authors:  I L Ke Nalbantoglu; Elizabeth M Brunt
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.